HLA-E is the ligand for the natural killer cell CD94/NKG2 receptors |
| |
Authors: | Phillip E. Posch Francisco Borrego Andrew G. Brooks John E. Coligan PhD |
| |
Affiliation: | (1) Structural Biology Section, National Institute of Allergy and Infectious Disease, National Institutes of Health, Twinbrook II, Rockville, Md., USA;(2) Laboratory of Immunogenetics, NIAID-NIH, Twinbrook II, 20852 Rockville, MD, USA |
| |
Abstract: | CD94/NKG2 is a recently described receptor present on natural killer (NK) cells and certain T cells that is composed of the CD94 chain covalently associated with a member of the NKG2 family of molecules. Both chains are glycosylated members of the C-type lectin superfamily. The CD94/NKG2 receptors are functionally heterogenous depending on which NKG2 family member is associated with CD94. Initially, it was thought that CD94/NKG2 receptors recognized a broad array of HLA-A, -B and -C (classical), as well as the nonclassical HLA-G, MHC class I molecules. Instead, recent data have suggested that this receptor is specific for HLA-E complexed with a peptide derived from the signal sequence (residues 3–11) of certain classical MHC class I molecules. Position 2 (residue 4) in the signal sequence derived peptides appears pivotal in determining whether the HLA-E/peptide complex confers resistance to NK-mediated lysis. The potential roles that the CD94/NKG2-HLA-E receptor ligand interaction might play in infection and tumor development are discussed. |
| |
Keywords: | Natural killer cells HLA-E CD94 NKG2 Major histocompatibility complex, class I |
本文献已被 SpringerLink 等数据库收录! |
|